• 70-chapter authoritative reference that covers therapeutic monoclonal antibody discovery, development, and clinical applications while incorporating principles, experimental data, and methodologies.
• First book to address the discovery and development of antibody therapeutics in their entirety.
• Most chapters contain experimental data to illustrate the principles described in them.
• Authors provide detailed methodologies that readers can take away with them and use in their own laboratories.

ZHIQIANG AN, PHD, is the Chief Scientific Officer of Epitomics, Inc., in Burlingame, California. Previously, he was Director of Biologics Research at Merck Research Laboratories, West Point, Pennsylvania. Dr. An started his biotech/pharmaceutical career at Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts. He received a doctor of philosophy degree from the University of Kentucky, Lexington, followed by postdoctoral training at the University of Wisconsin–Madison.